Testicular Cancer - Results from #90

The impact of testicular cancer and its treatment on masculinity: A systematic review. July 7, 2022

Management of Testicular Germ Cell Tumor With Somatic-Type Malignancy. July 6, 2022

A Role of the TEX101 Interactome in the Common Aetiology Behind Male Subfertility and Testicular Germ Cell Tumor. July 5, 2022

Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer. June 30, 2022

A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors. June 29, 2022

Metastatic testicular cancer presenting with hematuria and flank pain. June 27, 2022

A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention). June 20, 2022

Sperm-specific proteins: new implications for diagnostic development and cancer immunotherapy. June 20, 2022

Association study between polymorphisms in DNA methylation-related genes and testicular germ cell tumor risk. June 16, 2022

ACR Appropriateness Criteria® Staging and Surveillance of Testicular Cancer: 2021 Update. June 15, 2022

Process Evaluation of a Sport-Based Supportive Care Intervention for Testicular Cancer Survivors: A Mixed Methods Study. June 13, 2022

Long Non-Coding RNA RFPL3S Functions as a Biomarker of Prognostic and Immunotherapeutic Prediction in Testicular Germ Cell Tumor. June 9, 2022

Guideline discordant care in patients with metastatic germ cell tumors. June 8, 2022

Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors. June 3, 2022

Overcoming Chemotherapy Resistance in Germ Cell Tumors. May 30, 2022

Clinicopathologic predictors of outcomes in children with stage I testicular germ cell tumors: A pooled post hoc analysis of trials from the Children's Oncology Group. May 27, 2022

LINC00313 regulates the metastasis of testicular germ cell tumors through epithelial-mesenchyme transition and immune pathways. May 20, 2022

Shared-care survivorship program for testicular cancer patients: safe and feasible. May 19, 2022

Optimised detection of germ cell neoplasia in situ in contralateral biopsy reduces the risk of second testis cancer. May 18, 2022

Genomic Profile in a Non-Seminoma Testicular Germ-Cell Tumor Cohort Reveals a Potential Biomarker of Sensitivity to Platinum-Based Therapy. May 17, 2022

Page 5 of 82